SkyAI (SKYA) Volume Jumps 6.2x After Rebrand as Losses Widen
SkyAI (SKYA) shares saw volume surge to 6.2x the average as the unclassified fintech name trades at 0.35x book value despite a steep Q2 EPS miss.
signal:SKYA:2026-08-19 SkyAI (SKYA) Volume Jumps 6.2x After Rebrand as Losses Widen
SkyAI, Inc. (SKYA) shares saw trading volume surge to 6.2x the 20-day average, a sharp jump in attention for a stock still digesting a Q2 report that showed earnings per share fall to $(0.32) from $3.58 a year earlier, even as shares trade at just 0.35x book value — a combination that puts SKYA on the watchlist for investors screening for deep asset-value discounts overshadowed by deteriorating fundamentals.
The activity also follows a quarter in which SkyAI missed consensus EPS estimates by roughly 320%, posting a loss of $4.33 per share against an expected $(1.03) loss — a divergence wide enough to warrant a closer look, even against a broader macro backdrop of subdued volatility, with the VIX sitting at 14.9.
Key Facts
| Stock name | SKYA |
|---|---|
| Ticker | SKYA |
| Market | NASDAQ |
| Sector | Unclassified |
| Volume (x average) | 6.2x |
| Signal price | $1.27 |
SkyAI, Inc. is building what it describes as an agentic finance platform for the global south, combining stablecoin rails with AI to deliver financial access, education, and actionable intelligence to underbanked users across Asia, Latin America, and Africa. The company was formerly known as Sharps Technology, Inc. before changing its name to SkyAI in May 2026. Incorporated in 2017, the company is based in Melville, New York.
Recent Analyst Coverage
External analyst opinions (not investment advice): (2026-05-01)
| Strong Buy | 2 |
|---|---|
| Buy | 4 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
Peer Companies
RXST, OSUR, ACU, UTMD, XTNT
Risk Factors
The valuation discount here comes with a catch: a PBR of 0.35x sits alongside an ROE of -141.2% and a negative EV/EBITDA of -1.5x, a combination that fits the profile of a classic value trap — cheap on book value, but with profitability metrics deteriorating fast enough to question whether the discount reflects opportunity or ongoing structural decline. The company's transition from its prior identity as Sharps Technology into a stablecoin-and-AI finance platform serving underbanked markets in Asia, Latin America, and Africa also means SKYA carries the execution risk of an early-stage business pivot, layered on top of a loss that missed estimates by roughly 320% last quarter.
Macro conditions are comparatively calm, with the VIX at 14.9 and the 10-year Treasury yield flat over the past month at 4.65%, but the dollar index has fallen 2.3% over the same span — a trend worth monitoring given SKYA's business model rests on stablecoin rails that are inherently dollar-linked, so shifts in the dollar could cut either way for a platform built around cross-border, dollar-denominated financial access.
Recent Disclosures
Recent News
- 2026-08-19 Here are the top movers in Wednesday's session.
- 2026-08-10 SkyAI Q2 EPS $(0.32) Down From $3.58 YoY
- 2026-07-24 12 Health Care Stocks Moving In Friday's Pre-Market Session
Earnings Trend
| Fiscal Year | Revenue | Net Income |
|---|---|---|
| 2023 | - | $-10M |
| 2024 | - | $-9M |
| 2025 | $0M | $-283M |
Pre-Trade Checklist
| Business & competitive edge understood | ✅ Company profile summarized above |
|---|---|
| Leading sector | ⚠️ Not flagged as a leading sector |
| Good news already priced in? | ⚠️ 밸류트랩 후보(저평가 지표 대비 ROE/부채비율 약함 — 구조적 하락 가능성 점검 필요) |
| Stop-loss / take-profit set | ✅ Stop-loss -10% / first take-profit +20% set in advance |
| Exit plan if wrong | ✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support |
Trade Levels
| Signal price | $1.27 |
|---|---|
| Stop-loss | $1.14 (-10% from signal price) |
| First take-profit | $1.52 (+20% from signal price) |
| Trailing stop | 10% from peak |
| Invalidation | Close back below key support ($1.23) |
For now, SKYA reads as a name to watch rather than act on: the volume surge and steep valuation discount are notable, but the balance-sheet weakness argues for a defined risk framework if the setup is followed at all. Against the current signal price of $1.27, the range to track runs from a $1.14 stop-loss on the downside to an initial $1.52 target, with a close back below the $1.23 support level marking the point at which this setup's thesis would break down.